| Q1 2024 |
34 |
$161M |
+$19.2M |
-$9.57M |
+$9.61M |
APLT, BHVNXXXX, ALDX, AVDL, GLD, ENTX |
13F-HR |
5/15/2024, 04:05 PM |
| Q4 2023 |
32 |
$121M |
+$20.9M |
-$7.51M |
+$13.4M |
BHVNXXXX, ALDX, APLT, AVDL, SIL, HOOK |
13F-HR |
2/14/2024, 04:07 PM |
| Q3 2023 |
36 |
$95.6M |
+$25M |
-$1.24M |
+$23.8M |
ALDX, APLT, BHVNXXXX, AVDL, HOOK, VRNA |
13F-HR |
11/14/2023, 04:17 PM |
| Q2 2023 |
25 |
$80.7M |
+$21M |
$0 |
+$21M |
ALDX, BHVNXXXX, AVDL, HOOK, APLT, VRNA |
13F-HR |
8/15/2023, 07:50 AM |
| Q1 2023 |
26 |
$64.9M |
+$16.4M |
|
+$16.4M |
ALDX, BHVNXXXX, AVDL, VRNA, GDX, ENTX |
13F-HR |
5/15/2023, 04:25 PM |
| Q4 2022 |
21 |
$44.3M |
+$12.2M |
-$9.43M |
+$2.76M |
ALDX, BHVNXXXX, ALT, GDX, SIL, VRNA |
13F-HR |
2/14/2023, 03:06 PM |
| Q3 2022 |
33 |
$171M |
+$3.01M |
-$7.17M |
-$4.16M |
BHVNXXXX, ALDX, ENTX, ALT, ORGS, CVS |
13F-HR |
11/14/2022, 03:03 PM |
| Q2 2022 |
41 |
$175M |
+$7.52M |
-$150K |
+$7.37M |
BHVNXXXX, ALDX, EIGR, ENTX, ORGS, ALT |
13F-HR |
8/15/2022, 05:22 PM |
| Q1 2022 |
41 |
$159M |
+$5.54M |
-$1.58M |
+$3.96M |
BHVNXXXX, ENTX, EIGR, ORGS, ALDX, CRBPXXXX |
13F-HR |
5/16/2022, 04:13 PM |
| Q4 2021 |
38 |
$182M |
+$9.02M |
-$421K |
+$8.6M |
BHVNXXXX, APLT, ENTX, ORGS, EIGR, CRBPXXXX |
13F-HR |
2/14/2022, 03:04 PM |
| Q3 2021 |
40 |
$201M |
+$1.85M |
-$3.55M |
-$1.7M |
BHVNXXXX, APLT, ENTX, ORGS, CRBPXXXX, ALDX |
13F-HR |
11/15/2021, 03:05 PM |
| Q2 2021 |
42 |
$191M |
+$9.47M |
-$971K |
+$8.5M |
BHVNXXXX, APLT, ENTX, CRBPXXXX, ORGS, ALDX |
13F-HR |
8/16/2021, 04:05 PM |
| Q1 2021 |
39 |
$153M |
+$16.2M |
-$44.4K |
+$16.2M |
BHVNXXXX, APLT, CRBPXXXX, ORGS, ENTX, ALDX |
13F-HR |
6/14/2021, 01:34 PM |
| Q4 2020 |
31 |
$147M |
+$4.62M |
|
+$4.62M |
BHVNXXXX, APLT, EIGR, CRBPXXXX, ORGS, ABEO |
13F-HR |
2/16/2021, 03:08 PM |
| Q3 2020 |
30 |
$122M |
+$7.5M |
-$471K |
+$7.03M |
BHVNXXXX, APLT, CRBPXXXX, ORGS, EIGR, ALDX |
13F-HR |
11/16/2020, 03:08 PM |
| Q2 2020 |
19 |
$173M |
+$8.77M |
-$2.25M |
+$6.53M |
BHVNXXXX, CRBPXXXX, APLT, ABEO, ORGS, EIGR |
13F-HR |
8/14/2020, 04:11 PM |
| Q1 2020 |
18 |
$106M |
+$7.02M |
-$3.33M |
+$3.69M |
BHVNXXXX, CRBPXXXX, APLT, ABEO, BXXXXX, ENTX |
13F-HR |
5/15/2020, 04:01 PM |
| Q4 2019 |
18 |
$135M |
+$8.46M |
-$963K |
+$7.49M |
BHVNXXXX, CRBPXXXX, APLT, ABEO, BXXXXX, EIGR |
13F-HR |
2/14/2020, 04:08 PM |
| Q3 2019 |
23 |
$109M |
+$7.7M |
-$1.66M |
+$6.04M |
BHVNXXXX, CRBPXXXX, BXXXXX, ABEO, APLT, KRYS |
13F-HR |
11/14/2019, 03:11 PM |
| Q2 2019 |
22 |
$122M |
+$12M |
-$2.53M |
+$9.43M |
CRBPXXXX, BHVNXXXX, ABEO, BXXXXX, KRYS, MO |
13F-HR |
8/14/2019, 04:04 PM |
| Q1 2019 |
17 |
$132M |
+$24.8M |
-$2.99M |
+$21.8M |
BHVNXXXX, CRBPXXXX, ABEO, KRYS, BXXXXX, MO |
13F-HR |
5/15/2019, 04:06 PM |
| Q4 2018 |
15 |
$87.9M |
+$460K |
-$9.74K |
+$450K |
BHVNXXXX, CRBPXXXX, ABEO, KRYS, ALDX, ECORXXXX |
13F-HR |
2/14/2019, 03:59 PM |
| Q3 2018 |
17 |
$118M |
+$5.81M |
-$85.9K |
+$5.73M |
CRBPXXXX, ABEO, BHVNXXXX, ALDX, ECORXXXX, KRYS |
13F-HR |
11/14/2018, 03:04 PM |
| Q2 2018 |
19 |
$118M |
+$12.6M |
|
+$12.6M |
ABEO, BHVNXXXX, CRBPXXXX, ECORXXXX, AMPE, KRYS |
13F-HR |
8/14/2018, 04:03 PM |
| Q1 2018 |
13 |
$97.4M |
+$741K |
-$1.54M |
-$801K |
ABEO, CRBPXXXX, BHVNXXXX, AMPE, KRYS, VBLT |
13F-HR |
5/15/2018, 04:04 PM |
| Q4 2017 |
12 |
$113M |
+$3.04M |
-$324K |
+$2.72M |
ABEO, CRBPXXXX, BHVNXXXX, AMPE, VBLT, KRYS |
13F-HR |
2/14/2018, 03:26 PM |
| Q3 2017 |
16 |
$117M |
+$3.16M |
-$508K |
+$2.65M |
ABEO, BHVNXXXX, CRBPXXXX, VBLT, AVXL, KRYS |
13F-HR |
11/14/2017, 03:16 PM |
| Q2 2017 |
15 |
$75.4M |
+$20.3M |
-$74.3K |
+$20.2M |
CRBPXXXX, BHVNXXXX, ABEO, AVXL, VBLT, VNRX |
13F-HR |
8/14/2017, 04:28 PM |
| Q1 2017 |
17 |
$66.3M |
+$13.1M |
-$271K |
+$12.8M |
CRBPXXXX, ABEO, VBLT, AVXL, NLNK, AMPE |
13F-HR |
5/15/2017, 04:17 PM |
| Q4 2016 |
17 |
$57M |
+$9.22M |
-$1.79M |
+$7.42M |
CRBPXXXX, ABEO, VBLT, AVXL, RTTR, ADHD |
13F-HR |
2/14/2017, 04:07 PM |
| Q3 2016 |
18 |
$57M |
+$869K |
-$2.76M |
-$1.9M |
CRBPXXXX, ABEO, SYN, VBLT, CEMP, ADXSXXXX |
13F-HR |
11/14/2016, 05:23 PM |
| Q2 2016 |
22 |
$309M |
+$3.97M |
-$271K |
+$3.7M |
MDVN, CRBPXXXX, SYN, ADHD, AMPE, VBLT |
13F-HR |
8/15/2016, 04:06 PM |
| Q1 2016 |
22 |
$246M |
+$1.64M |
-$217K |
+$1.42M |
MDVN, SYN, AMPE, CRBPXXXX, ADHD, ABEO |
13F-HR |
5/16/2016, 04:09 PM |
| Q4 2015 |
21 |
$270M |
+$7.78M |
-$787K |
+$6.99M |
MDVN, AMPE, SYN, ADHD, CEMP, ABEO |
13F-HR |
2/17/2016, 01:29 PM |
| Q3 2015 |
19 |
$236M |
+$95.8M |
-$40K |
+$95.7M |
MDVN, AMPE, SYN, ADHD, ABEO, CRBPXXXX |
13F-HR |
11/16/2015, 03:14 PM |
| Q2 2015 |
19 |
$310M |
+$14.1M |
-$26.6K |
+$14.1M |
MDVN, SYN, AMPE, ADHD, ABEO, ADXSXXXX |
13F-HR |
8/14/2015, 04:23 PM |
| Q1 2015 |
17 |
$343M |
+$7.97M |
-$5.89M |
+$2.08M |
MDVN, AMPE, SYN, ADHD, NLNK, ADXSXXXX |
13F-HR |
5/15/2015, 04:10 PM |
| Q4 2014 |
14 |
$254M |
+$4.75M |
-$810K |
+$3.94M |
MDVN, AMPE, SYN, ADHD, NLNK, KERX |
13F-HR |
2/17/2015, 03:05 PM |
| Q3 2014 |
1 |
$2.46M |
|
|
|
ORPN |
NEW HOLDINGS |
12/9/2014, 09:35 AM |
| Q3 2014 |
15 |
$257M |
+$3.94M |
-$4.13M |
-$193K |
MDVN, AMPE, ADHD, KERX, ORPN, SYN |
13F-HR |
11/14/2014, 03:11 PM |
| Q2 2014 |
15 |
$224M |
+$1.28M |
-$52.9K |
+$1.23M |
MDVN, AMPE, ADHD, KERX, SYN, NLNK |
13F-HR |
8/14/2014, 04:16 PM |
| Q1 2014 |
16 |
$193M |
+$9.14M |
-$13.9M |
-$4.79M |
MDVN, AMPE, ADHD, SYN, KERX, NLNK |
13F-HR |
5/15/2014, 04:41 PM |
| Q4 2013 |
14 |
$199M |
|
|
|
MDVN, AMPE, ADHD, KERX, SQNM, SYN |
13F-HR |
2/14/2014, 03:13 PM |